title: A young Hispanic with c.1646G>A mutation exhibits severe cystic fibrosis lung disease: is ivacaftor an option for therapy?
authors.forename: Sunitha
authors.initials: S
authors.lastname: Yarlagadda
authors.forename: Weiqiang
authors.initials: W
authors.lastname: Zhang
authors.forename: Himabindu
authors.initials: H
authors.lastname: Penmatsa
authors.forename: Aixia
authors.initials: A
authors.lastname: Ren
authors.forename: Kavisha
authors.initials: K
authors.lastname: Arora
authors.forename: Anjaparavanda P
authors.initials: AP
authors.lastname: Naren
authors.forename: Fatima Anmol I
authors.initials: FA
authors.lastname: Khan
authors.forename: Catherine A
authors.initials: CA
authors.lastname: Donnellan
authors.forename: Saumini
authors.initials: S
authors.lastname: Srinivasan
authors.forename: Dennis C
authors.initials: DC
authors.lastname: Stokes
authors.forename: John C
authors.initials: JC
authors.lastname: Kappes
mesh_terms: D000627:Aminophenols / Q000627:therapeutic use*; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D005260:Female; D006630:Hispanic or Latino / Q000235:genetics; D006801:Humans; D015363:Quinolones / Q000627:therapeutic use*
chemical_list: D000627:Aminophenols; D015363:Quinolones; C545203:ivacaftor